// App-Quantinova.ai

SUN-088 : Targeting Androgen-Repressed and Androgen-Induced Genes: Combination Therapy a More Plausible Treatment Conduit for Castration Resistant Prostate Cancer?

Researchers

Presenter

  • Gang Wang

Principal Investigators

  • Nasrin R Mawji

  • Marianne D Sadar

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Abelson murine leukemia viral oncogene homolog 2

  • Androgen receptor variant 7

  • Phosphoserine Aminotransferase 1

  • Tissue factor pathway inhibitor

  • TNF Receptor Superfamily Member 21

  • Ubiquitin Conjugating Enzyme E2 C

Drug/Treatment

  • Enzalutamide

  • Bicalutamide

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved